AGC Biologics vs Northway Biotech: CDMO Comparison
How does AGC Biologics compare to Northway Biotech?
As of Nov 2026, AGC Biologics: 4 FDA inspections (including 1 NAI, 3 VAI and 0 OAI), 27 EMA/MHRA GMP certificates. Signal Score 79.9. Northway Biotech: no FDA inspections on file, 8 EMA/MHRA GMP certificates. Signal Score 80.8. Counts are the established FDA, EMA and MHRA records on each profile. CDMOs cannot pay to change a score.
Side-by-side comparison of AGC Biologics and Northway Biotech on independent FDA inspections, EMA and MHRA GMP certificates, clinical-program activity, and CDMO Signal Score. Data sourced from FDA, EMA EudraGMDP, MHRA GMDP, and ClinicalTrials.gov.
Key differences
- AGC Biologics has more FDA inspections on record (4 vs 0) — a deeper regulatory paper trail.
- Both maintain clean enforcement records — no FDA OAI classifications or warning letters on file for either CDMO.
- AGC Biologics has materially broader EMA GMP coverage (27 active certificates vs 8) — stronger EU footprint.
Across the cross-modality scorecard, Northway Biotech carries the higher composite Signal Score — but the right choice depends on the specific modality, phase, and geography of the program.
Frequently asked: AGC Biologics vs Northway Biotech
How does AGC Biologics compare to Northway Biotech?
On CDMO Signal's composite Signal Score, AGC Biologics is 80/100 and Northway Biotech is 81/100; AGC Biologics has 4 FDA inspections on record vs 0 for Northway Biotech; European coverage is 27 active EMA+MHRA certificates for AGC Biologics vs 8 for Northway Biotech. Both are tracked in the CDMO Signal directory. The scorecard above breaks down every metric side by side — use it alongside each CDMO's individual profile for the full regulatory and clinical footprint.
Which has the stronger FDA inspection record, AGC Biologics or Northway Biotech?
Both AGC Biologics and Northway Biotech maintain clean enforcement records on file — no FDA warning letters and no OAI classifications. AGC Biologics has 4 FDA inspections on record; Northway Biotech has 0.
How do AGC Biologics and Northway Biotech compare on European GMP coverage?
AGC Biologics holds 27 active EMA GMP certificates and 0 MHRA / UK certificates. Northway Biotech holds 8 active EMA GMP certificates and 0 MHRA / UK certificates. Use these counts as a proxy for the breadth of each CDMO's European regulatory footprint.
Which is more active in clinical-stage manufacturing — AGC Biologics or Northway Biotech?
AGC Biologics is matched to 2 ClinicalTrials.gov records as a manufacturing partner; Northway Biotech is matched to 0. Higher counts indicate broader sponsor exposure but say nothing about approved-product track record — pair this number with each CDMO's profile page for context.
What does the Signal Score gap mean in practice?
AGC Biologics carries a Signal Score of 80/100 and Northway Biotech carries 81/100 — essentially tied for Northway Biotech. The Signal Score combines quality (FDA inspections + EMA/MHRA GMP), operational performance, financial stability, and capacity intelligence. CDMOs cannot pay to influence their score.
Use the free AI matchmaker to weigh both against your specific requirements — capacity, modality, regulatory record, geography — and surface other qualified options.
Find & compare CDMOs →